Top Non Invasive Device Solution Companies - 2020
Dominion Aesthetic Technologies: New Gold Standard in Abdominal Fat Reduction

Top 10 Non Invasive Device Solution Companies - 2020

In the past couple of years, technology has been crucial for numerous breakthroughs in the medical device industry. One such example is the manufacturing of non-invasive medical devices. Today, the use of non-invasive tools has permeated fields like cardiology, neurology, oncology, and others. To further bolster the performance of these equipment, manufacturers are heavily investing in the latest technologies, such as IoT. Amalgamating IoT in the non-invasive device design and development has opened doors for personalized and predictive treatment processes by transmitting real-time health data from the patient to the physician. The interconnectedness fostered by IoT devices such as smart wearables and table-top devices establish a steady two-way communication pathway between healthcare providers and patients. The devices periodically alert physicians about a patients’ health and also alerts them of any inconsistencies observed. Also, healthcare providers are resorting to big data, machine learning algorithms, blockchain technology, and others to handle the humongous data generated per patient

In the wake of such drastic transitions, we have compiled this issue of MedTech Outlook in order to assist organizations in the task of finding accomplished solution providers to help them navigate the vast non-invasive device realm. In this edition, we have listed the top 10 Non Invasive Device Solution Providers 2020 to highlight the enterprises that can escalate the chances of your growth. Equipped with innovative technological capabilities, these enlisted solution providers are transforming the non-invasive device landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts and CXOs in the medical device sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of MedTech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology.

We present to you MedTech Outlook’s “Top 10 Non Invasive Device Solution Providers - 2020.”

    Top Non Invasive Device Solution Companies

    Cognoptix
    Cognoptix is one of the pioneers in the early detection of Alzheimer’s disease and is very unique in this field. The company uses its non-invasive device, Sapphire II to detect traces of amyloid in the patients’ eyes to determine if they have AD. It is currently developing a combined optical scanning device and ophthalmic ligand. The company is proactively collaborating with pharma partners and academic institutes while preparing its diagnostic platform. The Sapphire II platform is a compact and easy to use clinical device for in-situ patient examination and is currently available for investigational use only
    Dominion Aesthetic Technologies
    A Texas-based medical devices company, Dominion Aesthetic Technologies has developed eon, the world’s first non-contact laser device which is FDA-cleared for abdominal fat reduction and designed with several unique features. In contrast with other energy-based treatments for fat reduction, eon has a novel and highly effective cooling system that maintains patient comfort while the laser reduces the unwanted fat tissue. The device works by inducing apoptosis, a process that gently kills the fat cells, which are eliminated through the lymphatic system and normal urination
    Esaote
    Esaote is one of the six largest Ultrasound system in the world by volume, with more than 130,000 portable and cart-based units installed globally. Besides scientific and clinical advances, Esaote has always focused on flexible systems with a high degree of configuration and users’ preferences. This is what its customers appreciated most as distinctive Italian style and design. During Covid-19, Esaote has been in the front-line with the healthcare providers with its powerful compact ultrasounds to be used at the bed side with the highest safety conditions. The company was pivotal in introducing its Interventional Imaging solution where images from other modalities like MRI/CT/PET are fused with Ultrasound to increase guiding accuracy in tumor ablation and removal
    Speclipse
    Speclipse is widely known as a developer of a patented non-invasive, in-vivo skin cancer diagnostic solution, Spectra-Scope. The device diagnoses skin cancer with the utmost efficiency and accuracy by detecting skin tissue biochemical information through laser-induced plasma spectroscopy (LIPS). This enables patients to get rid of an unnecessary biopsy. Establishing the company with a single product and growing over the years, Speclipse is catering to a wide range of skincare clinics that currently conducts skin check-up or/and skin biopsy. Striding forward, the company envisions a partnership with the dealers to engage in local sales activities. Also, several laser companies and medical device companies are interested in partnering with Speclipse to repurpose their core technology for more specialized applications
    CDx Diagnostics
    The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. CDx tests require only a few minutes of practice time, are highly cost-effective, widely reimbursed, and address a recognized critical gap in the current diagnostic standard of care that results in thousands of otherwise unnecessary cancer deaths each year. Routine clinical use of CDx testing has already detected thousands of precancerous cells that would otherwise have been missed in time for effective endoscopic treatment and application of the CDx diagnostic platform to prevent cancers of the bile duct, stomach, and IBD affected colon is currently in progress
    Circularity Healthcare
    Circularity Healthcare, LLC is an emerging multinational leader in noninvasive transdermal and circulatory health technologies. D'OXYVA® (doxyhemoglobin vasodilator) is Circularity's first clinically studied, trademarked, and patented transdermal delivery system, which is the latest breakthrough in the field of autonomic nervous system (ANS), cardiovascular, and microvascular applications. It is named after the two main mechanisms of action related to its solution; deoxyhemoglobin vasodilator
    Integrity Applications
    Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea
    Johari Digital
    Johari Digital Healthcare designs, develops, engineers and produces electronic healthcare devices to be distributed worldwide. Johari Digital is one of the first MDSAP and US FDA certified GMP audited manufacturing company in India. It is first company to get US FDA clearance for their electro medicine device in 1986 and further continued to get more than 15 products FDA certified for professionals in physical therapy and medical aesthetic, sports medicine and neuro-rehab
    Neuronetics
    With NeuroStar Advanced Therapy, Neuronetics, Inc., is the market leader in Transcranial Magnetic Stimulation technology for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. We are the first company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant medication. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world
    NovaSignal
    NovaSignal Corp. is a medical technology company whose mission is to save lives by unlocking the hidden power of blood flow data. The company’s FDA-cleared Lucid™ Robotic System combines non-invasive ultrasound, robotics, and artificial intelligence to assess real-time cerebral blood flow. Through the use of cloud computing and data analytics services, NovaSignal will support physicians in their clinical decision making, leading to better patient outcomes